Moo-Il Kang

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Clinical, Histopathological, and Molecular Characteristics of Papillary Thyroid Microcarcinoma

Dong‐Jun Lim, Ki‐Hyun Baek, Youn‐Soo Lee et al. · Thyroid · 2007 · 76 citations

Medicine, Oncology, Pathology +17

Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein

Eun‐Jung Rhee, Won‐Young Lee, Se-Yeon Kim et al. · Clinical Science · 2005 · 75 citations

Medicine, Cardiology, Bone Metabolism +15

Relationship between metabolic syndrome and thyroid nodules in healthy Koreans

Juyoung Shin, Min‐Hee Kim, Kun‐Ho Yoon et al. · The Korean Journal of Internal Medicine · 2015 · 67 citations · Full text

Medicine, Endocrinology, Radiology +13

The effects of thyrotropin-suppressing therapy on bone metabolism in patients with well-differentiated thyroid carcinoma

Mee Kyoung Kim, Kyung‐Jin Yun, Min‐Hee Kim et al. · Bone · 2014 · 59 citations

Medicine, Oncology, Pharmacology +15